ALVO - Alvotech S.A. Net earnings per share (EPS TTM)

Symbol and logo of brand Alvotech SA (ALVO)

Patent rights battles and pricing wars with original drug developers drive the business dynamics of Alvotech (ALVO). This rolling annual EPS chart demonstrates financial resilience, with the current figure standing at -0.56. The company's strategy is based on creating affordable biosimilar versions of expensive blockbusters, which ensures stable demand. Growth is scaled through strategic alliances with global distributors to capture international markets.

ALVO (Alvotech) Net earnings per one share for the last twelve months history from 04/28/2023 to 11/11/2026

Summary analytical data breakdowns for Alvotech S.A. (ALVO)

- share price and expert price forecast:
Stock Quotes Alvotech|ALVO - Analyst Forecast Prices
- market capitalization statistics:
Market Capitalization Alvotech SA|ALVO - Value Adjusted for Debt and Cash
- business book valuation details:
Book Value per Share Alvotech|ALVO - Total Stockholders' Equity|Market Value to Book Value Ratio alvotech.com|ALVO - Aggregate Asset Value
- debt obligations and liquidity statistics:
Total Debt to Capital Alvotech|ALVO - Long-Term Debt to Capital|Short-Term Debt to Equity Alvotech Corp|ALVO - Company Debts|Debt to Book Value Alvotech SA|ALVO - Company Long-Term Debt|Company Short-Term Debt Alvotech|Quick Liquidity Indicator alvotech.com
- net income and valuation multiples indicators:
ALVO - Profit After Payment of Taxes|Projected Future Earnings Alvotech|ALVO - Market Cap to Earnings|Forward P/E Multiple Alvotech SA|ALVO - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Alvotech SA|ALVO - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Alvotech|ALVO - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months alvotech.com|ALVO - Earnings per share growth in current year|Expected earnings per share growth for next year Alvotech
Fundamental company valuation:Alvotech - ALVO
Manufactured products of Alvotech Corp

Investors assess the resilience of Alvotech (ALVO) through net earnings per share, calculated by dividing total annual income by the total number of securities. The earnings per share trend over the last 12 months reflects the company's ability to monetize complex biosimilars while overcoming patent disputes with pharma behemoths and high technological barriers to market entry.

Competitor analysis for Alvotech

HLN: Net earnings per share for the last 12 months|kenvue.com - Earnings per share for the last four quarters|VRNA: Net earnings per share (EPS TTM)|Jyong Biotech Limited - Earnings per share for the trailing year|LGND (Ligand Pharma) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Amneal Corp AMRX|Earnings per share for the last twelve months Perrigo Company plc (PRGO)|LQDA (liquidia.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) GLPG (Galapagos)|Net earnings per share (EPS TTM) ANI Pharmaceuticals Inc ANIP|MNKD - Earnings per share for the last twelve months|AMPH: Earnings per share for the last twelve months|PCRX (Pacira BioSciences) - Net earnings per share for the last 12 months|SPRY (ars-pharma.com) - Earnings per share for the last twelve months|Earnings per share for the last twelve months Theravance Biopharma, Inc.|Net earnings per one share for the last twelve months Aquestive Therapeutics Inc AQST|Net earnings per share for the last 12 months SCPH (scPharmaceuticals Inc.)|Earnings per share for the last four quarters TECX|Net earnings per share (EPS TTM) TNXP (Tonix Pharmaceuticals)|SXT Pharmaceuticals (SXTC) - Net earnings per one share for the last twelve months|Eupraxia Pharma - Net earnings per share (EPS TTM)|BioHarvest Sciences, Inc. (BHST) - Net earnings per share for the last 12 months|EXOZ: Net earnings per share (EPS TTM)|Oramed Pharmaceuticals Inc. - Earnings per share for the trailing year|ENTX (Entera Bio Ltd) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) ipatherapeutics.com|Earnings per share for the last twelve months ABVC BioPharma, Inc. (ABVC)|Earnings per share for the last twelve months CPIX (Cumberland Pharmaceuticals Inc)|Quantum BioPharma Limited - Net earnings per share for the last 12 months|FibroGen Corporation - Earnings per share for the last twelve months|TELO - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Rani Therapeutics|synergychc.com (SNYR) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months RLYB (Rallybio)|LEXX (Lexaria Bioscience Corp) - Net earnings per share (EPS TTM)|PULM: Earnings per share for the trailing year|Net earnings per share (EPS TTM) PTHL|Net earnings per share (EPS TTM) aptorumgroup.com (APM)|Earnings per share for the last twelve months Lyra Therapeutics LYRA|Earnings per share for the trailing year IBO|TNFA - Earnings per share for the last twelve months|cbdMD, Inc. (YCBD) - Net earnings per share for the last 12 months|PRFX: Net earnings per share (EPS TTM)|Altamira Therapeutics Ltd. (CYTO) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months LIPO|OPTN: Earnings per share for the trailing year|Earnings per share for the last twelve months Pieris (PIRS)|PROC - Net earnings per one share for the last twelve months|Petros Pharmaceuticals - Net earnings per share for the last 12 months|Earnings per share for the last four quarters QLI (qlsyy.net)|ACELYRIN - Net earnings per share (EPS TTM)|Earnings per share for the trailing year TFFP (TFF Pharmaceuticals Inc.)